FR3635M - Pharmaceutical preparations for the treatment of cardio-circulatory disorders, based on 1,4-benzodioxane derivatives. - Google Patents

Pharmaceutical preparations for the treatment of cardio-circulatory disorders, based on 1,4-benzodioxane derivatives.

Info

Publication number
FR3635M
FR3635M FR975017A FR975017A FR3635M FR 3635 M FR3635 M FR 3635M FR 975017 A FR975017 A FR 975017A FR 975017 A FR975017 A FR 975017A FR 3635 M FR3635 M FR 3635M
Authority
FR
France
Prior art keywords
cardio
treatment
pharmaceutical preparations
circulatory disorders
benzodioxane derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR975017A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siphar SA
Original Assignee
Siphar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siphar SA filed Critical Siphar SA
Application granted granted Critical
Publication of FR3635M publication Critical patent/FR3635M/en
Priority claimed from CH5176A external-priority patent/CH612562B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR975017A 1964-03-06 1964-05-19 Pharmaceutical preparations for the treatment of cardio-circulatory disorders, based on 1,4-benzodioxane derivatives. Expired FR3635M (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH290564 1964-03-06
CH5176A CH612562B (en) 1976-01-06 1976-01-06 METHOD OF COLORING TEXTILE MATERIAL.

Publications (1)

Publication Number Publication Date
FR3635M true FR3635M (en) 1965-10-25

Family

ID=88697413

Family Applications (1)

Application Number Title Priority Date Filing Date
FR975017A Expired FR3635M (en) 1964-03-06 1964-05-19 Pharmaceutical preparations for the treatment of cardio-circulatory disorders, based on 1,4-benzodioxane derivatives.

Country Status (1)

Country Link
FR (1) FR3635M (en)

Similar Documents

Publication Publication Date Title
FR2427M (en) Bacteriotherapeutic drug, in particular for the treatment of gastrointestinal disorders.
FR3043M (en) Medicinal product based on a new series of 1-aryl-4-oxo-1,3,8-triazaspiro- (4,5) -decanes, substituted in position 8 or their salts for the treatment of mental disorders.
FR3069M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR1448790A (en) Process for the preparation of alpha-monochloro-nu, nu-dialkoyl-aceto-acetamides
FR3672M (en) Medicinal product based on nicotinic acid derivatives for the treatment of circulatory disorders.
FR2243M (en) New drugs, based on optically active naphthalene derivatives, for the treatment of heart disease.
FR2963M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR3635M (en) Pharmaceutical preparations for the treatment of cardio-circulatory disorders, based on 1,4-benzodioxane derivatives.
FR2739M (en) New drug, in particular for the treatment of blood coagulability disorders.
NL153084B (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS FOR THE ORAL TREATMENT OF SEBORRHOEA, AND THE PREPARATIONS OBTAINED.
FR2576M (en) New drug, in particular for the treatment of blood coagulability disorders.
FR1447514A (en) Process for the preparation of l - (-) - beta- (3. 4-dihydroxy-phenyl) -alpha-methyl-alanine
FR1967M (en) Medicines based on 1,3,4, -thiadiazole derivatives for the treatment of epilepsy.
FR3153M (en) Drug for the treatment of coronary heart disease, based on isopropylidene-2 ', 3' adenosine.
FR3880M (en) New drugs, especially for the treatment of tuberculosis.
OA01758A (en) Process for the preparation of pharmaceutical compositions.
FR3077M (en) New drugs based on benzene derivatives for the treatment of coronary artery disease.
FR3173M (en) Therapeutic derivatives of aralkoyl-2-mercapto-benzazoles.
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.
FR3670M (en) New oral drug for the treatment of chronic tissue ulcerations.
FR2683M (en) New drug, in particular for the treatment of blood coagulability disorders.
FR2817M (en) Combinations of drugs for the treatment of mental disorders.
FR3064M (en) Medicines based on aryl-thio-aliphatic compounds for the treatment of atherosclerosis.
FR3526M (en) Therapeutic composition for the treatment of acne.
BE598665A (en) Pharmaceutical preparations for the treatment of leukemia.